Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07057206 · ClinicalTrials.gov registry record · Phase 1
Simultaneous Engagement of Networks for Alleviating Pain (SENAP)
A Phase 1 study, sponsored by University of Minnesota.
- Not yet
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT07057206 is a Phase 1 study that has not yet begun recruiting, run by University of Minnesota. The registered enrollment target is 20 participants.
The verdict
NCT07057206, a Phase 1 study, has not yet begun recruiting, sponsored by University of Minnesota.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This trial is investigating the acceptability and efficacy of PFM-guided cortical stimulation for the treatment of central neuropathic pain.
Interventions
- DEVICE PFM-guided cortical stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-11-01 |
| Est. Completion | 2030-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07057206
The ClinicalTrials.gov registry entry for NCT07057206 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PFM-guided cortical stimulation is the first listed.
NCT07057206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07057206 about?
NCT07057206 is a clinical study titled "Simultaneous Engagement of Networks for Alleviating Pain (SENAP)". This trial is investigating the acceptability and efficacy of PFM-guided cortical stimulation for the treatment of central neuropathic pain.
What is the current status of trial NCT07057206?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2026-11-01. Estimated completion is 2030-12.
What interventions are being tested in trial NCT07057206?
The interventions under investigation include: PFM-guided cortical stimulation (DEVICE).
Who is sponsoring clinical trial NCT07057206?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.